Literature DB >> 8129640

Electroencephalography as an aid in the exclusion of Alzheimer's disease.

D J Robinson1, H Merskey, W T Blume, R Fry, P C Williamson, V C Hachinski.   

Abstract

OBJECTIVE: To determine the usefulness or otherwise of the awake electroencephalogram (EEG) in the diagnosis of Alzheimer's disease (AD).
DESIGN: Prospective collection of one or more awake EEGs in patients diagnosed as having AD or mixed AD and multi-infarct dementia according to current systematic criteria with analysis of those cases confirmed by postmortem examination. Systematized blind interpretation of EEGs.
SETTING: Tertiary care practice with both ambulatory and hospitalized patients, ie, neurological department in general hospital and psychogeriatric unit in psychiatric hospital. PATIENTS: A series of 86 subjects with AD and 17 with mixed AD and multi-infarct dementia being those members of a consecutive series on whom postmortem information was available. Awake EEGs in 56 age- and sex-matched control subjects.
RESULTS: Seventy-five patients with AD (87.2%) and 13 of the mixed group (76.5%) had abnormal EEGs on first testing, giving a sensitivity of 87.2% for uncomplicated AD. Ultimately, 79 (92%) of 86 patients with AD had abnormal EEGs. Twenty (35%) of 56 EEGs for matching control subjects were abnormal. Moderately abnormal or severely abnormal EEGs were found in 10 (50%) of 20 of the patients with AD of less than 4 year's duration compared with two (4.1%) of 49 of the control subjects, giving a specificity of 95.9% for EEGs with this degree of abnormality. The normal EEG had a negative predictive value of 0.825 with respect to the diagnosis of AD in these populations.
CONCLUSIONS: Widespread availability, low cost, and high sensitivity support the use of the awake EEG in the diagnosis of AD.

Entities:  

Mesh:

Year:  1994        PMID: 8129640     DOI: 10.1001/archneur.1994.00540150074020

Source DB:  PubMed          Journal:  Arch Neurol        ISSN: 0003-9942


  3 in total

Review 1.  Novel roles of amyloid-beta precursor protein metabolites in fragile X syndrome and autism.

Authors:  C J Westmark; D K Sokol; B Maloney; D K Lahiri
Journal:  Mol Psychiatry       Date:  2016-08-30       Impact factor: 15.992

2.  Use of Jonkman et al. Score for Visual Quantification of Electroencephalography as a Tool to Assess Disease Severity in Cortical Dementias.

Authors:  R Kiran Kumar; Sadanandavalli Retnaswami Chandra; Girish B Kulkarni; Rose Dawn Bharath
Journal:  Indian J Psychol Med       Date:  2017 Mar-Apr

Review 3.  Vascular dementia: Diagnostic criteria and supplementary exams. Recommendations of the Scientific Department of Cognitive Neurology and Aging of the Brazilian Academy of Neurology. Part I.

Authors:  Eliasz Engelhardt; Carla Tocquer; Charles André; Denise Madeira Moreira; Ivan Hideyo Okamoto; José Luiz de Sá Cavalcanti
Journal:  Dement Neuropsychol       Date:  2011 Oct-Dec
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.